CELLULAR KINETICS IN RECTAL-CANCER

被引:31
作者
TERRY, NHA
MEISTRICH, ML
ROUBEIN, LD
LYNCH, PM
DUBROW, RA
RICH, TA
机构
[1] UNIV TEXAS, MD ANDERSON CANCER CTR, DEPT MED ONCOL, HOUSTON, TX 77030 USA
[2] UNIV TEXAS, MD ANDERSON CANCER CTR, DEPT DIAGNOST RADIOL, HOUSTON, TX 77030 USA
[3] UNIV TEXAS, MD ANDERSON CANCER CTR, DEPT CLIN RADIOTHERAPY, HOUSTON, TX 77030 USA
关键词
RECTAL CANCER; TUMOR CELL KINETICS; PREDICTIVE ASSAYS; POTENTIAL DOUBLING TIME; BROMODEOXYURIDINE LABELING INDEX; FLOW CYTOMETRY;
D O I
10.1038/bjc.1995.351
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Measurements of dynamic tumour cell kinetic parameters, particularly the potential doubling time (T-pot), may have potential as predictive assays for treatment outcome after radiotherapy. This paper details the distributions of T-pot and other kinetic and DNA content parameters measured in rectal cancers. Biopsies were taken from 119 patients approximately 6 h after infusion of 200 mg m(-2) bromodeoxyuridine (BrdUrd). The samples were analysed by bivariate DNA/BrdUrd flow cytometry. The primary purpose of the study was to measure the kinetic parameters of labelling index (LI), duration of S-phase (T-s) and T-pot. Secondarily, tumour DNA ploidy (DNA index) and S-phase fractions (SPFs) were also estimated from the univariate DNA histograms. The 101 evaluable patients were classified according to clinical stage as T2 (n = 12), T3 (n = 53), T4 (n = 28) or recurrent tumours (n = 8). Of the evaluable tumours, 73 were DNA aneuploid. The median LI, T-s, and T-pot of the aneuploid tumours were 21%, 20 h and 3.3 days respectively. The calculated LI, T-s, and T-pot of diploid rumours were subject to uncertainties because of the contribution of normal cells. The LI and SPF of all tumours were, however, significantly (P < 0.001) correlated, having a correlation coefficient of only 0.76. The wide distributions of values for LI (quartiles 13.5%, 26.9%) and T-pot (quartiles 2.4, 5.6 days) that were found are necessary baseline information if these parameters are to be useful in individual treatment selection or as predictors of treatment outcome.
引用
收藏
页码:435 / 441
页数:7
相关论文
共 36 条
[1]  
ALLISON DC, 1989, CANCER RES, V49, P1456
[2]  
ALLISON DC, 1985, CANCER RES, V45, P6010
[3]  
[Anonymous], 1985, NEW ENGL J MED, V312, P1465
[4]   CONSENSUS REVIEW OF THE CLINICAL UTILITY OF DNA FLOW-CYTOMETRY IN COLORECTAL-CANCER [J].
BAUER, KD ;
BAGWELL, CB ;
GIARETTI, W ;
MELAMED, M ;
ZARBO, RJ ;
WITZIG, TE ;
RABINOVITCH, PS .
CYTOMETRY, 1993, 14 (05) :486-491
[5]  
BAUER KD, 1993, CLIN FLOW CYTOMETRY, P307
[6]   A METHOD TO MEASURE THE DURATION OF DNA-SYNTHESIS AND THE POTENTIAL DOUBLING TIME FROM A SINGLE SAMPLE [J].
BEGG, AC ;
MCNALLY, NJ ;
SHRIEVE, DC ;
KARCHER, H .
CYTOMETRY, 1985, 6 (06) :620-626
[7]  
BEGG AC, 1992, SEMIN RADIAT ONCOL, V2, P22
[8]   MEASURING POTENTIAL DOUBLING TIMES OF MURINE TUMORS USING FLOW-CYTOMETRY [J].
CARLTON, JC ;
TERRY, NHA ;
WHITE, RA .
CYTOMETRY, 1991, 12 (07) :645-650
[9]   AUTORADIOGRAPHIC AND FLOW-CYTOMETRIC ASSESSMENT OF CELL-PROLIFERATION IN PRIMARY COLORECTAL-CANCER - RELATIONSHIP TO DNA PLOIDY AND CLINICOPATHOLOGICAL FEATURES [J].
COSTA, A ;
FARANDA, A ;
SCALMATI, A ;
QUAGLIUOLO, V ;
COLELLA, G ;
DELEON, MP ;
SILVESTRINI, R .
INTERNATIONAL JOURNAL OF CANCER, 1992, 50 (05) :719-723
[10]  
CRISSMAN JD, 1989, PATHOL ANNU, V24, P103